Kevin D. Deane, MD/PhD - Director
Dr. Deane is a Professor of Medicine in the Division of Rheumatology at the University of Colorado Anschutz Medical Campus. He has been PI or Co-I on multiple observational studies of preclinical rheumatoid arthritis; in addition, he was PI on the NIH-funded StopRA trial that studied the role of hydroxychloroquine to prevent or delay the onset of rheumatoid arthritis in high-risk individuals, with plans to do additional RA prevention studies in the near future.
Christopher Striebich, MD/PhD - Lead Clinical Trials Specialist
Dr. Striebich is an Associate Professor of Medicine in the Division of Rheumatology at the University of Colorado Anschutz Medical Campus. He has been PI or Co-I dozens of clinical trials in autoimmune disease, and was Co-Investigator on the NIH-funded StopRA trial that studied the role of hydroxychloroquine to prevent or delay the onset of rheumatoid arthritis in high-risk individuals.
Marie L. Feser, MSPH - Project Manager
Ms. Feser has extensive experience as project manager of studies in autoimmune diseases.
303-724-6896
Autoimmune Disease Prevention Center